Stereotaxis' MAGiC catheter received CE Mark approval in Europe, enabling the company to earn an additional $3k per procedure with +80% gross margins. FDA approval of MAGiC is expected by September.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback